CVS Group Plc risk profile

45 Elevated one input has moved against it

Measured 21 October 2026 from CVSG's filed statements. Recomputed nightly.

45 (Elevated), driven by Competitive position at 50, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation29NormalStableOne-year price volatility — 26.2%
Operating pressure49ElevatedWorseningCosts outgrowing revenue — +5.1 percentage points
Cash conversion34NormalStableCapital spending against operating cash — 0.64x
Leverage and coverage40ElevatedWorseningNet debt to EBITDA — 2.57x
Competitive position50ElevatedStableRevenue-growth gap against peers — -10.8 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for CVS Group Plc